129 related articles for article (PubMed ID: 414936)
1. Dopamine receptors in the central nervous system.
Seeman P; Tedesco JL; Lee T; Chau-Wong M; Muller P; Bowles J; Whitaker PM; McManus C; Tittler M; Weinreich P; Friend WC; Brown GM
Fed Proc; 1978 Feb; 37(2):131-6. PubMed ID: 414936
[TBL] [Abstract][Full Text] [Related]
2. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
Onali P; Olianas MC; Gessa GL
Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
[TBL] [Abstract][Full Text] [Related]
3. Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol.
Nowak JZ; Arbilla S; Galzin AM; Langer SZ
J Pharmacol Exp Ther; 1983 Aug; 226(2):558-64. PubMed ID: 6875865
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological and biochemical characterization of the D-1 dopamine receptor mediating acetylcholine release in rabbit retina.
Hensler JG; Cotterell DJ; Dubocovich ML
J Pharmacol Exp Ther; 1987 Dec; 243(3):857-67. PubMed ID: 2961878
[TBL] [Abstract][Full Text] [Related]
5. Long-term adaptive changes in striatal dopamine function in response to chronic neuroleptic intake in rats.
Jenner P; Kerwin R; Rupniak NM; Murugaiah K; Hall MD; Fleminger S; Marsden CD
J Neural Transm Suppl; 1983; 18():205-12. PubMed ID: 6135741
[TBL] [Abstract][Full Text] [Related]
6. Dopamine receptors and the dopamine hypothesis of schizophrenia.
Seeman P
Synapse; 1987; 1(2):133-52. PubMed ID: 2905529
[TBL] [Abstract][Full Text] [Related]
7. Characterization of D-2 dopamine receptors in a tumor of the rat anterior pituitary gland.
Lin C; McGonigle P; Molinoff PB
J Pharmacol Exp Ther; 1987 Sep; 242(3):950-6. PubMed ID: 2958621
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization of a rat dopamine D-2 receptor cDNA expressed in a mammalian cell line.
Neve KA; Henningsen RA; Bunzow JR; Civelli O
Mol Pharmacol; 1989 Sep; 36(3):446-51. PubMed ID: 2571073
[TBL] [Abstract][Full Text] [Related]
9. Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site.
Roseboom PH; Gnegy ME
Mol Pharmacol; 1989 Jan; 35(1):139-47. PubMed ID: 2563306
[TBL] [Abstract][Full Text] [Related]
10. Effect of haloperidol and apomorphine treatment on dopamine receptors in pituitary and striatum.
Friend WC; Brown GM; Jawahir G; Lee T; Seeman P
Am J Psychiatry; 1978 Jul; 135(7):839-41. PubMed ID: 665797
[TBL] [Abstract][Full Text] [Related]
11. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
Levant B; Grigoriadis DE; DeSouza EB
J Pharmacol Exp Ther; 1992 Sep; 262(3):929-35. PubMed ID: 1356154
[TBL] [Abstract][Full Text] [Related]
12. D-1 and D-2 dopamine receptor blockade: interactive effects in vitro and in vivo.
Saller CF; Salama AI
J Pharmacol Exp Ther; 1986 Mar; 236(3):714-20. PubMed ID: 3005552
[TBL] [Abstract][Full Text] [Related]
13. An analysis of the effects of apomorphine and haloperidol on the release of [3H]-dopamine and [3H]-noradrenaline from rabbit brain slices.
Kelly MJ
Arch Int Pharmacodyn Ther; 1981 Mar; 250(1):18-29. PubMed ID: 7271378
[TBL] [Abstract][Full Text] [Related]
14. New detection of brain dopamine receptors with (3H)dihydroergocryptine.
Tittler M; Weinreich P; Seeman P
Proc Natl Acad Sci U S A; 1977 Sep; 74(9):3750-3. PubMed ID: 410026
[TBL] [Abstract][Full Text] [Related]
15. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
Leff SE; Creese I
Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
[TBL] [Abstract][Full Text] [Related]
16. Selective labeling of apomorphine receptors by 3H-LSD.
Whitaker PM; Seeman P
Eur J Pharmacol; 1979 Jun; 56(3):269-71. PubMed ID: 225177
[TBL] [Abstract][Full Text] [Related]
17. Selective labeling of alpha-adrenergic receptors in caudate nucleus by [3H] dihydroergocryptine in the presence of spiperone-blocked dopamine receptors.
Titeler M; Seeman P
Proc Natl Acad Sci U S A; 1978 May; 75(5):2249-53. PubMed ID: 27786
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
Enjalbert A; Bockaert J
Mol Pharmacol; 1983 May; 23(3):576-84. PubMed ID: 6306429
[TBL] [Abstract][Full Text] [Related]
19. Changes in the sensitivity to apomorphine of dopamine receptors modulating dopamine and acetylcholine release after chronic treatment with bromocriptine or haloperidol.
Cubeddu LX; Hoffmann IS; James MK; Niedzwiecki DM
J Pharmacol Exp Ther; 1983 Sep; 226(3):680-5. PubMed ID: 6887008
[TBL] [Abstract][Full Text] [Related]
20. Dopamine receptor binding of a novel dibenzodioxazocine derivative, EGYT-2509.
Gyüre K; Szentendrei T; Kanyicska B; Fekete MI; Rónai AZ
Pol J Pharmacol Pharm; 1985; 37(3):253-61. PubMed ID: 2866498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
